Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning
- Algoritmes
- Behandeling op maat
- Betaaltitel
- Biomarker
- cfDNA
- DNA
- Educatie
- Geen onderdeel van een categorie
- GENAYA project
- Hartwig Medical Database
- Hartwig Medical Foundation
- Hergebruik data
- Innovatie
- IT
- Kwaliteit
- Lab proces
- Lerend zorgsysteem
- Medicijn
- Moleculaire diagnostiek
- OncoAct
- oncoanalyser
- OncoAnalyser Dx
- Onderzoek
- Participerende ziekenhuizen
- Pipeline
- Preventie
- Primaire Tumor Onbekend
- Uitbehandeld
- Verhalen patiënten
- Werken in de cloud
- Wetenschappelijke publicaties
- Whole genome sequencing
- Zeldzame kankers
Predicting response to enzalutamide and abiraterone in metastatic prostate cancer using whole-omics machine learning
Anouk C. De Jong, Alexandra Danyi, Job Van Riet, Ronald De Wit, Martin Sjöström, Felix Feng, Jeroen De Ridder & …
Copy number footprints of platinum-based anticancer therapies
Santiago Gonzalez, Nuria Lopez-Bigas, Abel Gonzalez-Perez & Dmitry A. Gordenin PLOS Genetics, 2023, DOI
Identifying somatic changes in drug transporters using whole genome and transcriptome sequencing data of advanced tumors
Wesley S. Van De Geer, Ron H.J. Mathijssen, Job Van Riet, Neeltje Steeghs, Mariette Labots, Carla Van Herpen, Lot A. …
Tumour mutations in long noncoding RNAs enhance cell fitness
Roberta Esposito, Andrés Lanzós, Tina Uroda, Sunandini Ramnarayanan, Isabel Büchi, Taisia Polidori, Hugo Guillen-Ramirez, Ante Mihaljevic, Bernard Mefi Merlin, Lia …
Genetic immune escape landscape in primary and metastatic cancer
Francisco Martínez-Jiménez, Peter Priestley, Charles Shale, Jonathan Baber, Erik Rozemuller & Edwin Cuppen Nature Genetics, 2023, DOI
The ratio of adaptive to innate immune cells differs between genders and associates with improved prognosis and response to immunotherapy
Johanne Ahrenfeldt, Ditte S. Christensen, Andreas B. Østergaard, Judit Kisistók, Mateo Sokač, Nicolai J. Birkbak & Albert Rübben PLOS ONE, …
Using genomic scars to select immunotherapy beneficiaries in advanced non-small cell lung cancer
H. C. Donker, B. Van Es, M. Tamminga, G. A. Lunter, L. C. L. T. Van Kempen, E. Schuuring, T. …
Hotspot propensity across mutational processes
Claudia Arnedo-Pac, Ferran Muiños, Abel Gonzalez-Perez & Nuria Lopez-Bigas Molecular Systems Biology, 2023, DOI
Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLC
Sophie M. Ernst, Joanne M. Mankor, Job Van Riet, Jan H. Von Der Thüsen, Hendrikus J. Dubbink, Joachim G.J.V. Aerts, …
Pan-cancer association of DNA repair deficiencies with whole-genome mutational patterns
Simon Grund Sørensen, Amruta Shrikhande, Gustav Alexander Poulsgaard, Mikkel Hovden Christensen, Johanna Bertl, Britt Elmedal Laursen, Eva R Hoffmann & …
ERα-associated translocations underlie oncogene amplifications in breast cancer
Jake June-Koo Lee, Youngsook Lucy Jung, Taek-Chin Cheong, Jose Espejo Valle-Inclan, Chong Chu, Doga C. Gulhan, Viktor Ljungström, Hu Jin, …
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours
Birgit S. Geurts, Thomas W. Battaglia, J. Maxime Van Berge Henegouwen, Laurien J. Zeverijn, Gijs F. De Wit, Louisa R. …
Het aantal WGS- samples dat Hartwig Medical Foundation heeft, is uniek in het onderzoeksveld en groeit snel. Toen we begonnen waren het er 3.500 en dat zijn er nu al meer dan 5.000.